Q Therapeutics, Inc.
company.status.inactiveCIK 1366541fmd_0B7QZPCRQ2HDZXFXGV7GJDB9KEManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jun 01, 2006 to Sep 30, 2015, 28 periods
| Line item | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | 0 | 0 | 0 | 0 | 1 |
| Cost of revenue | – | – | – | – | – | – | 0 | 0 |
| Gross profit | – | – | – | – | – | 0 | 0 | 1 |
| Research and development | – | – | – | 1 | 0 | 2 | 2 | 2 |
| Total operating expenses | – | – | – | 1 | 2 | 4 | 3 | 4 |
| Operating income | – | – | – | (1) | (2) | (3) | (3) | (3) |
| Interest expense | – | – | – | 0 | 1 | 0 | 0 | 0 |
| Interest and investment income | – | – | – | – | 0 | 0 | – | – |
| Other non-operating income (expense) | – | – | – | 0 | (1) | 0 | (0) | 0 |
| Income before taxes | – | – | – | (1) | (3) | (3) | (3) | (3) |
| Income tax expense | – | – | – | – | 0 | 0 | – | – |
| Net income from continuing operations | – | – | – | – | (3) | (3) | – | – |
| Net income | (0) | (0) | (1) | (1) | (3) | (3) | (3) | (3) |